1. Home
  2. QGEN vs TEM Comparison

QGEN vs TEM Comparison

Compare QGEN & TEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QGEN
  • TEM
  • Stock Information
  • Founded
  • QGEN 1986
  • TEM 2015
  • Country
  • QGEN Netherlands
  • TEM United States
  • Employees
  • QGEN N/A
  • TEM N/A
  • Industry
  • QGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • TEM
  • Sector
  • QGEN Health Care
  • TEM
  • Exchange
  • QGEN Nasdaq
  • TEM NYSE
  • Market Cap
  • QGEN 9.9B
  • TEM 8.0B
  • IPO Year
  • QGEN 1996
  • TEM 2024
  • Fundamental
  • Price
  • QGEN $38.18
  • TEM $42.59
  • Analyst Decision
  • QGEN Buy
  • TEM Buy
  • Analyst Count
  • QGEN 8
  • TEM 11
  • Target Price
  • QGEN $49.79
  • TEM $61.22
  • AVG Volume (30 Days)
  • QGEN 1.1M
  • TEM 10.0M
  • Earning Date
  • QGEN 04-28-2025
  • TEM 05-17-2025
  • Dividend Yield
  • QGEN 3.27%
  • TEM N/A
  • EPS Growth
  • QGEN N/A
  • TEM N/A
  • EPS
  • QGEN 0.38
  • TEM N/A
  • Revenue
  • QGEN $1,978,214,000.00
  • TEM $693,398,000.00
  • Revenue This Year
  • QGEN $5.15
  • TEM $77.53
  • Revenue Next Year
  • QGEN $6.49
  • TEM $24.94
  • P/E Ratio
  • QGEN $105.15
  • TEM N/A
  • Revenue Growth
  • QGEN 0.66
  • TEM 30.38
  • 52 Week Low
  • QGEN $37.63
  • TEM $22.89
  • 52 Week High
  • QGEN $47.93
  • TEM $91.45
  • Technical
  • Relative Strength Index (RSI)
  • QGEN 43.07
  • TEM N/A
  • Support Level
  • QGEN $39.32
  • TEM N/A
  • Resistance Level
  • QGEN $41.44
  • TEM N/A
  • Average True Range (ATR)
  • QGEN 0.63
  • TEM 0.00
  • MACD
  • QGEN 0.09
  • TEM 0.00
  • Stochastic Oscillator
  • QGEN 0.21
  • TEM 0.00

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

About TEM TEMPUS AI INC

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Share on Social Networks: